Диссертация (1139777), страница 22
Текст из файла (страница 22)
et al. Role of 18F-cholinePET/CT in biochemically relapsed prostate cancer after radical prostatectomy:correlation with trigger PSA, PSA velocity, PSA doubling time, and metastaticdistribution. // Clin Nucl Med. 2013; 38(1): e26–32.195.Castellucci P., Ceci F., Graziani T. et al. Early biochemical relapse afterradical prostatectomy: which prostate cancer patients may benefit from restaging11C-Choline PET/CT scan before salvage radiation therapy? // J Nucl Med, 2014;55(9): 1424–1429.196.Kjolhede H., Ahlgren G., Almquist H.
et al. 18F-choline PET/CT for earlydetectionodmetastasesinbiochemicalrecurrencefollowingradicalprostatectomy. // World J Urol, 2015; 33(11): 1749–1752.197.Mamede M., Ceci F., Castellucci P. et al. The role of 11 C-choline petimaging in the early detection of recurrence in surgically treated prostate cancerpatients with very low PSA level < 0.5 ng/mL. // Clin Nucl Med, 2013; 38: e342–345.132198.Moul J.W. Prostate Specific antigen only progression of prostate cancer. // JUrol, 2000; 163: 1632–1642.199.Roberts S.G., Blute M.L., Bergstralh E.J. et al.
PSA doubling time as apredictor of clinical progression after biochemical failure following radicalprostatectomy for prostate cancer. // Mayo Clin Proc, 2001; 76: 576–581.200.Matrone F., Sivolella S., Bellavita R. et al. Use of 18F-choline positronemission tomography/CT in high-risk prostate cancer: a case of solitary adrenalmetastasis. // Tumori, 2015; 101(1): e21–23.201.Алексеев Б.Я.
Нетипичная локализация метастаза в мочеточнике убольного кастрационно-рефрактерным раком предстательной железы.Клинический случай и обзор литературы / Б.Я. Алексеев, К.М. Нюшко, А.С.Калпинский [и др.] // Онкоурология. – 2014. – №1. – С. 82–87.202.Mydlo J.H., Agins J.A., Donohoe J., Grob B.M. A review of urologic cancerpatients with multiple primary malignancies. // World J Urol, 2001; 19: 240–243.203.Yhim H.Y., Kim H.S., Lee N.R. et al. Quadruple primary malignancies ofliver, bladder, lung and stomach in one patient.
// Tumori, 2010; 96: 787–791.204.Чиссов В.И.Развитиеученияопервичноймножественностизлокачественных опухолей. // Первично-множественные злокачественныеопухоли, под ред. В. И. Чиссова, А.Х. Трахтенберга М. — 2000. — С. 7–29.205.Soerjomataram I. Epidemiology of multiple primary cancers / I.Soerjomata-ram, J.W. Coebergh // Methods Mol. Biol, 2009; 471: 85–105.206.Ганов Д.И. Первично-множественный рак предстательной железы вАлтайском крае / Д.И.
Ганов, С.А. Варламов, А.Ф. Лазарев // Онкоурология.– 2010. – №1. – С. 50–51.207.Garcia J.R., Ponce A., Canales M. Et al. Detection of second tumors in11C-choline PET/C studies performed due to biochemical recurrence of prostatecancer. // Rev Esp Med Nucl Imagen Mol. 2014; 33 (1): 28–31.208.Goineau A., Colombie M. Rousseau C. et al. Incidental Detection of aHodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18F-FDG ina Patient With Prostate Cancer. // Clin Nucl Med, 2015; 40(8): 670–671.133209.Garzon J.G., Bassa P., Moragas M. et al. Incidental diagnosis of diffuselarge B-cell lymphoma by 11C-choline PET/CT in a patient with biochemicalrecurrence of prostate cancer.
// Clin Nucl Med, 2014; 39(8), P. 742–743.210.Tuscano C., Russi E.G., Al Sayyad S., Pergolizzi S. An Incidental Finding ofMuscinous Colon Cancer by (18)F-Choline PET/CT Determining a Change inClinical Management of a Patient with Recurrent Prostate Adenocarcinoma. //Case Rep Oncol Med, 2014; 2014: 297031.211.Bertagna F., Bertoli M., Treglia G.
et al. Incidental 11C-choline PET/CTuptake due to esophageal carcinoma in a patient studied for prostate cancer. //Clin Nucl Med, 2014; 39(10): 442–444.212.Freesmeyer M., Drescher R., Winkens T. Unexpected diagnosis ofperipheral schwannoma on 18F-fluoroethylcholine PET/CT for localization ofprostate cancer recurrence and biopsy under real-time PET/ultrasound fusionguidance. // Clin Nucl Med, 2014; 39(4): 385–386.134.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
